ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

anastrozole, Quantity: 1 mg

Saadav alates:

Strides Pharma Science Pty Ltd

INN (Rahvusvaheline Nimetus):

Anastrozole

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Manustamisviis:

Oral

Ühikuid pakis:

30 tablets

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Toote kokkuvõte:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2012-09-24